You are using an older browser version. Please use a supported version for the best MSN experience.

TD Health Sciences - A

TDB132
32.54
+0.54
+1.70%
2017-10-20
5 Years
  • Previous Close

    31.99

  • Net Assets

    106.10M

  • Yield

    0.00%

  • Front load

    None

  • Expenses

    -

  • Category

    Sector Equity

  • Morningstar Risk

    Above Average

  • Morningstar Rating ★★★★
Profile

Name of Issuer

TD Asset Management Inc

Fund Style

Open

Fund Manager

Ziad Bakri

Investment Style

Large Growth

The fundamental investment objective of the Fund is to achieve long-term capital appreciation by investing primarily in equity securities of companies located in the United States and other countries, that are engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. Health sciences companies are defined as those companies that commit or derive at least 50% of their assets, revenues, or operating profits from the activities just described.

Purchase Information

Initial Purchase 500
Initial Purchase: IRA 500
Initial Purchase: AIP 500

Inception

2000-11-01

AdChoices
AdChoices
AdChoices
image beaconimage beaconimage beacon